Royalty Pharma PLC (RPRX)
25.80
+0.10
(+0.37%)
USD |
NASDAQ |
Nov 18, 16:00
25.80
0.00 (0.00%)
After-Hours: 20:00
Royalty Pharma Profit Margin (Quarterly): 96.33% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 96.33% |
| June 30, 2024 | 18.99% |
| March 31, 2024 | 0.84% |
| December 31, 2023 | 82.93% |
| September 30, 2023 | 13.45% |
| June 30, 2023 | 42.29% |
| March 31, 2023 | 49.82% |
| December 31, 2022 | -80.62% |
| September 30, 2022 | 24.88% |
| June 30, 2022 | 56.82% |
| March 31, 2022 | 9.21% |
| December 31, 2021 | 1.37% |
| Date | Value |
|---|---|
| September 30, 2021 | 17.40% |
| June 30, 2021 | 79.42% |
| March 31, 2021 | 12.06% |
| December 31, 2020 | 29.90% |
| September 30, 2020 | 53.98% |
| June 30, 2020 | 86.52% |
| March 31, 2020 | 14.22% |
| December 31, 2019 | |
| September 30, 2019 | 88.09% |
| June 30, 2019 | 33.15% |
| March 31, 2019 | 84.49% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-80.62%
Minimum
Dec 2022
96.33%
Maximum
Sep 2024
32.10%
Average
24.88%
Median
Sep 2022
Profit Margin (Quarterly) Benchmarks
| Geron Corp | -93.55% |
| Amicus Therapeutics Inc | -4.75% |
| Ionis Pharmaceuticals Inc | -105.0% |
| Arbutus Biopharma Corp | -1.47K% |
| Syndax Pharmaceuticals Inc | -673.0% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 11.56% |
| Return on Assets | 6.81% |
| Return on Invested Capital | 6.89% |